(19)
(11) EP 1 729 772 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.04.2017 Bulletin 2017/16

(45) Mention of the grant of the patent:
07.12.2016 Bulletin 2016/49

(21) Application number: 05726105.9

(22) Date of filing: 23.03.2005
(51) International Patent Classification (IPC): 
C07D 409/14(2006.01)
C07D 413/14(2006.01)
 C07D 401/14(2006.01)
C07D 401/04(2006.01)
(86) International application number:
PCT/US2005/009810
(87) International publication number:
WO 2005/094514 (13.10.2005 Gazette 2005/41)

(54)

HETEROARYL PIPERIDINE GLYCINE TRANSPORTER INHIBITORS

HETEROARYL-PIPERIDIN-GLYCIN-TRANSPORTERHEMMER

INHIBITEURS DU TRANSPORTEUR DE GLYCINE A BASE D'HETEROARYLPIPERIDINE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
LV

(30) Priority: 24.03.2004 US 555925 P

(43) Date of publication of application:
13.12.2006 Bulletin 2006/50

(73) Proprietors:
  • Merck Sharp & Dohme Corp.
    Rahway, NJ 07065-0907 (US)
  • MERCK SHARP & DOHME LTD.
    Hoddesdon, Hertfordshire EN11 9BU (GB)

(72) Inventors:
  • BLACKABY, Wesley
    Hoddesdon Hertfordshire EN11 9BU (GB)
  • DUGGAN, Mark, E.
    Rahway, New Jersey 07065-0907 (US)
  • HALLETT, David
    Hoddesdon Hertfordshire EN11 9BU (GB)
  • HARTMAN, George, D.
    Rahway, NJ 07065-0907 (US)
  • JENNINGS, Andrew, S.
    Hoddesdon Hertfordshire EN11 9BU (GB)
  • LEISTER, William, H.
    Rahway, NJ 07065-0907 (US)
  • LEWIS, Richard, T.
    Hoddesdon Hertfordshire EN11 9BU (GB)
  • LINDSLEY, Craig, W.
    Rahway, New Jersey 0706-0907 (US)
  • NAYLOR, Elizabeth
    Hoddesdon Hertfordshire EN11 9BU (GB)
  • STREET, Leslie, J.
    Hoddesdon Hertfordshire EN11 9BU (GB)
  • WANG, Yi
    Rahway, NJ 07065-0907 (US)
  • WISNOSKI, David, D.
    Rahway, NJ 07065-0907 (US)
  • WOLKENBERG, Scott, E.
    Rahway, NJ 07065-0907 (US)
  • ZHAO, Zhijian
    Rahway, NJ 07065-0907 (US)

(74) Representative: Horgan, James Michael Frederic et al
Merck Sharp & Dohme Limited European Patent Department Hertford Road
Hoddesdon, Herts. EN11 9BU
Hoddesdon, Herts. EN11 9BU (GB)


(56) References cited: : 
US-A1- 2003 013 720
 US-B2- 6 664 273
   
  • WERMUTH C G.: 'The Practice of Medicinal Chemistry.', 1996, ACADEMIC PRESS. pages 211 - 213, XP008062324
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).